ATOS Archived Articles
Atossa Therapeutics (ATOS): A Promising Biopharmaceutical Tackling Breast Cancer Head-On
Published on March 15, 2025
Atossa Therapeutics, Inc. (NASDAQ:ATOS): Navigating the Complexities of Breast Cancer Treatment with Innovative (Z)-Endoxifen
Published on September 24, 2024